Globus Medical (GMED) Long-Term Deferred Tax (2011 - 2026)

Globus Medical (GMED) has reported Long-Term Deferred Tax for 16 consecutive years, with $224.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Long-Term Deferred Tax fell 18.58% year-over-year to $224.6 million; the trailing twelve-month figure through Jun 2026 stood at $224.6 million (down 18.58% YoY), and the FY2025 full-year result was $218.2 million, up 131.65% from the prior year.
• Long-Term Deferred Tax climbed to $224.6 million in Q2 2026 per GMED's latest filing, from $214.8 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $275.9 million in Q2 2025 and bottomed at $7.3 million in Q3 2023.
• Historically, Long-Term Deferred Tax has averaged $96.7 million across 5 years, with a median of $50.0 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Long-Term Deferred Tax tumbled 83.64% in 2023, then surged 1416.0% in 2025.
• Over 5 years, Long-Term Deferred Tax stood at $48.8 million in 2022, then sank by 78.12% to $10.7 million in 2023, then surged by 781.61% to $94.2 million in 2024, then soared by 131.65% to $218.2 million in 2025, then climbed by 2.94% to $224.6 million in 2026.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $224.6 million, $214.8 million, and $218.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.